Salvador Rico

pharma-biotechhealthcare-services

Is this you? Claim this profile →

No public contact links on file.

Speaking history

American Society of Gene & Cell Therapy Annual Meeting

3 May 2027 Philadelphia, United States “Safety and efficacy of ETX101, an investigational AAV9-based gene therapy for SCN1A+ Dravet syndrome: Interim results from the POLARIS Phase 1/2 clinical trials”

Topics this speaker covers

pharma-biotechhealthcare-services

Sectors

healthcare_medtech_pharma

Sourcing speakers for your event?

Browse the speaker directory →